Peptonic's patent application is approved in the US as first country
Peptonic Medical AB (publ) today announced that the application to patent its intimate cleanser in US will be approved on June 20th 2023, this according to information from the USPTO (United States Patent and Trademark Office).“This is an important step to increase the attractiveness of our portfolio in the eyes of consumers and distribution partners in the US”, says Erik Sundquist, CEO of Peptonic Medical The global intimate cleanser market is ca 1.2 billion USD growing at an annual rate of ca 3,5%. Somewhat simplified the market constitutes of soaps and oils. With soaps there is a risk